Ticker
SAGECompany Name
SAGE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
6/30/2025 | $ 422.92M | $ 68.94M | $ 353.99M | $ 0 |
3/31/2025 | $ 469.67M | $ 46.67M | $ 423M | $ 0 |
12/31/2024 | $ 547.22M | $ 82.47M | $ 464.75M | $ 0 |
9/30/2024 | $ 622.43M | $ 100.96M | $ 521.47M | $ 0 |
6/30/2024 | $ 697.11M | $ 101.23M | $ 595.87M | $ 0 |
3/31/2024 | $ 767.6M | $ 175.49M | $ 592.12M | $ 0 |
12/31/2023 | $ 882.28M | $ 72.32M | $ 809.95M | $ 0 |
9/30/2023 | $ 949.66M | $ 150.04M | $ 799.62M | $ 0 |
6/30/2023 | $ 1.08B | $ 122.75M | $ 959.54M | $ 0 |
3/31/2023 | $ 1.22B | $ 207.83M | $ 1.01B | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for SAGE THERAPEUTICS INC is calculated as follows: Assets [ $ 738.63M ] - Intangibles [ $ 0 ] - CashnEq [ $ 186.64M ]
(=) Core Assets [ $ 551.99M ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.36B |
average | $ 798.36M |
median | $ 287.51M |
std | $ 1.05B |